Published in Lancet on September 25, 1982
Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev (1991) 7.12
Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol (1988) 4.27
Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients. J Clin Microbiol (1993) 2.73
Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa. J Clin Microbiol (1989) 2.04
Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe. Epidemiol Infect (1989) 1.69
Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients. J Clin Microbiol (1991) 1.50
Pseudomonas aeruginosa genotype prevalence in Dutch cystic fibrosis patients and age dependency of colonization by various P. aeruginosa sequence types. J Clin Microbiol (2009) 1.21
Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa. J Clin Microbiol (2000) 1.05
Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain. J Clin Microbiol (2014) 0.90
Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp. J R Soc Med (2003) 0.80
Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis (2001) 5.07
Serratia marcescens. J Med Microbiol (1997) 3.64
New method for detecting slime production by coagulase negative staphylococci. J Clin Pathol (1989) 3.07
The relations of emotionality and regulation to dispositional and situational empathy-related responding. J Pers Soc Psychol (1994) 2.31
Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun (1996) 2.13
Revised guidelines for control of MRSA: applying appropriately-based recommendations. J Hosp Infect (1999) 2.02
Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut (1999) 1.87
Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med (1998) 1.84
Enterobacter cloacae in a haematology/oncology ward--first impressions. J Hosp Infect (1989) 1.61
Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial. Gut (1988) 1.61
The expanded spectrum of toxocaral disease. Lancet (1988) 1.60
The effect of bile acids on the growth and adherence of Helicobacter pylori. Aliment Pharmacol Ther (1991) 1.56
Small intestine peroral biopsy in coeliac children. Gut (1966) 1.50
Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens. Am J Gastroenterol (1995) 1.43
Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro. J Antimicrob Chemother (1996) 1.42
Educational value of printed information for patients with hypertension. Br Med J (Clin Res Ed) (1981) 1.42
Colicin V production by clinical isolates of Escherichia coli. Infect Immun (1981) 1.41
Diffuse panbronchiolitis: East meets West. Eur Respir J (2007) 1.40
A differential response to treatment with divalproex sodium in patients with intractable headache. Cephalalgia (1994) 1.39
Laparoscopic transabdominal preperitoneal (TAPP) hernia repair. A 7-year two-center experience in 3017patients. Surg Endosc (2001) 1.38
Epidemiological typing of MRSA isolates from blood cultures taken in Irish hospitals participating in the European Antimicrobial Resistance Surveillance System (1999-2003). Eur J Clin Microbiol Infect Dis (2006) 1.30
Isolated pulmonary vein atresia. Br Heart J (1990) 1.26
RO 15-1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability. Br J Clin Pharmacol (1982) 1.24
Gentamicin and methicillin resistant Staphylococcus aureus in Dublin hospitals: clinical and laboratory studies. J Med Microbiol (1983) 1.22
Investigation in man of the efficacy of a benzodiazepine antagonist, Ro 15-1788. Lancet (1981) 1.22
High prevalence of familial sarcoidosis in an Irish population. Thorax (1984) 1.20
Determination of the optimal transport system for Helicobacter pylori cultures. J Med Microbiol (1993) 1.18
Antibiotic resistance in Providencia stuartii isolated in hospitals. J Clin Microbiol (1981) 1.18
Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance. Dig Dis Sci (1997) 1.18
Coagulase testing compared with commercial kits for routinely identifying Staphylococcus aureus. J Clin Pathol (1990) 1.15
Unusual clustering of allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Pediatrics (1988) 1.15
Enterobacter in hospital. J Hosp Infect (1992) 1.15
Enhanced cultivation of Helicobacter pylori in liquid media. J Clin Pathol (1993) 1.15
Acetamide broth for isolation of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol (1983) 1.14
Absence of central effects in man of the benzodiazepine antagonist Ro 15-1788. Psychopharmacology (Berl) (1983) 1.14
Bacteriocins: nature, function and structure. Micron (1996) 1.14
Circumcision and periurethral carriage of Proteus mirabilis in boys. Arch Dis Child (1988) 1.14
Atopy and bronchial reactivity in older patients with cystic fibrosis. Thorax (1980) 1.14
Enterotoxin production by Staphylococcus aureus isolates from cases of septicaemia and from healthy carriers. J Med Microbiol (1989) 1.13
Recovery from severe paraquat poisoning following forced diuresis and immunosuppressive therapy. J Ir Med Assoc (1971) 1.12
Providencia stuartii infections: a review of 117 cases over an eight year period. J Hosp Infect (1981) 1.11
Assessing individual quality of life in amyotrophic lateral sclerosis. Qual Life Res (2001) 1.11
Atopy, immunological changes, and respiratory function in bronchiectasis. Thorax (1984) 1.10
Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis. Thorax (1988) 1.10
In vitro adhesiveness and biotype of Gardnerella vaginalis strains in relation to the occurrence of clue cells in vaginal discharges. Genitourin Med (1987) 1.09
Susceptibility to antimicrobial agents and analysis of plasmids in gentamicin- and methicillin-resistant Staphylococcus aureus from Dublin hospitals. J Med Microbiol (1985) 1.08
Cross infection in a surgical ward caused by Pseudomonas aeruginosa with transferable resistance to gentamicin and tobramycin. J Clin Pathol (1977) 1.08
Letter: Providencia stuartii infections. Lancet (1975) 1.08
alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis. Am Rev Respir Dis (1993) 1.08
Bacteraemia in Dublin due to gentamicin-resistant Staphylococcus aureus. J Hosp Infect (1981) 1.07
Urinary tract infection in female patients -a survey in general practice in the Dublin area. Ir Med J (1982) 1.07
Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa. J Infect Dis (1990) 1.07
Meconium ileus equivalent in older patients with cystic fibrosis. Br Med J (Clin Res Ed) (1983) 1.07
A review of drug addict abscesses. Ir Med J (1984) 1.07
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF. Eur Respir J (2002) 1.07
Management of high blood pressure in general practice. Ir Med J (1982) 1.07
Antimicrobial chemotherapy of septicemia due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1985) 1.07
Quality of life: impact of chronic illness on the partner. J R Soc Med (2001) 1.07
Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori. Antimicrob Agents Chemother (1994) 1.06
Two gas-gangrene-like infections due to Bacillus cereus. Br J Surg (1979) 1.06
Lancefield group C streptococcal endocarditis. Thorax (1974) 1.05
Vancomycin toxicity: a prospective study. J Antimicrob Chemother (1985) 1.04
Antibiotics for the prevention of septicaemia in urology. J Antimicrob Chemother (1982) 1.04
An epidemiological study of Candida species infection in cancer patients using genetic fingerprinting and morphotyping. J Hosp Infect (1995) 1.04
Relations between desire for early death, depressive symptoms and antidepressant prescribing in terminally ill patients with cancer. J R Soc Med (2002) 1.03
Pre-formed urease activity of Helicobacter pylori as determined by a viable cell count technique--clinical implications. J Med Microbiol (1994) 1.02
Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes. Dig Dis Sci (1997) 1.02
Importation of methicillin-resistant Staphylococcus aureus from Baghdad to Dublin and subsequent nosocomial spread. J Hosp Infect (1990) 1.02
Granulomatous hepatitis of obscure aetiology. Diagnostic contribution of Kveim testing and anti-tuberculous therapy. Q J Med (1971) 1.02
Strain variation in the MRSA population over a 10-year period in one Dublin hospital. Eur J Clin Microbiol Infect Dis (2002) 1.02
A comparison of the mental status, personality profiles and life events of patients with irritable bowel syndrome and peptic ulcer disease. Acta Psychiatr Scand (1991) 1.01
Quality of life in patients with intermittent claudication: relationship with laboratory exercise performance. Vasc Med (1996) 1.01
Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation. Thorax (1989) 1.01
Nocturnal deaths among patients with chronic bronchitis and emphysema. Br Med J (Clin Res Ed) (1984) 0.99
A new methicillin- and gentamicin-resistant Staphylococcus aureus in Dublin: molecular genetic analysis. J Med Microbiol (1989) 0.99
Culture of Helicobacter pylori under aerobic conditions on solid media. Eur J Clin Microbiol Infect Dis (1994) 0.98
Antimicrobial resistance and epidemiological typing of methicillin-resistant Staphylococcus aureus in Ireland (North and South), 1999. Eur J Clin Microbiol Infect Dis (2003) 0.97
Prevalence of metronidazole-resistant Helicobacter pylori in dyspeptic patients. Ir J Med Sci (1993) 0.97
Obstructive sleep apnea following topical oropharyngeal anesthesia in loud snorers. Am Rev Respir Dis (1991) 0.97
Sternal and costochondral infections with gentamicin and methicillin resistant Staphylococcus aureus following thoracic surgery. Scand J Infect Dis (1983) 0.97
The prevalence of methicillin-resistant staphylococcus aureus among the residents of six nursing homes for the elderly. J Hosp Infect (2000) 0.96
Epidemiology and susceptibility of serratia marcescens in a large general hospital over an 8-year period. J Hosp Infect (2000) 0.95
Altered gastrointestinal immune response in sarcoidosis. Gut (1988) 0.95
Severe staphylococcal infections treated with vancomycin. J Antimicrob Chemother (1982) 0.95
Fatal recurrence of neuroleptic malignant syndrome. Br J Psychiatry (1988) 0.95
Risk factors for colonization with methicillin-resistant Staphylococcus aureus among nursing home residents. J Hosp Infect (2000) 0.94
Prospective vs retrospective assessment of lower urinary tract symptoms in patients with advanced prostate cancer: the effect of 'response shift'. BJU Int (2003) 0.94
Fibronectin as an enhancer of nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages. Infect Immun (1989) 0.94
The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1985) 0.93
Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis. J Clin Invest (1991) 0.93
Molecular analysis of multiple-resistance plasmids transferred from gram-negative bacteria isolated in a urological unit. Antimicrob Agents Chemother (1985) 0.93
Neutrophil adhesion molecule surface expression and responsiveness in cystic fibrosis. Am J Respir Crit Care Med (1998) 0.93
Waterhouse-Friderichsen syndrome without purpura due to Haemophilus influenzae group B. Postgrad Med J (1985) 0.93